Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
POM121 transmembrane nucleoporin like 9, pseudogene (POM121L9P) is a transcribed pseudogene found in humans. It is inferred to be a pseudogene because protein homology is limited to the first of seven exons, suggesting it does not produce a functional protein and is likely subject to rapid degradation through nonsense-mediated decay. As a pseudogene, POM121L9P does not encode a functional product and is not considered a therapeutic target. There is no evidence linking this locus to biological function, disease relevance, drug interactions, or biomarker applications[3]. The name and aliases largely reflect its similarity to the POM121 family of nuclear pore complex proteins, but all current information supports its status as an inactive genetic element[3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on POM121 transmembrane nucleoporin like 9, pseudogene (POM121L9P).